Holen Sie sich die Stockscreener-App
280.85
0.76%
-2.14
Handel nachbörslich:
280.85
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LH?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$282.99
Offen:
$283.05
24-Stunden-Volumen:
405.89K
Relative Volume:
0.58
Marktkapitalisierung:
$23.14B
Einnahmen:
$13.77B
Nettoeinkommen (Verlust:
$856.40M
KGV:
27.58
EPS:
10.1824
Netto-Cashflow:
$1.38B
1W Leistung:
-0.68%
1M Leistung:
+1.70%
6M Leistung:
+2.04%
1J Leistung:
+9.36%
1-Tages-Spanne:
$279.23
$283.53
1-Wochen-Bereich:
$278.70
$290.65
52-Wochen-Spanne:
$209.38
$293.72
Labcorp Holdings Inc Stock (LH) Company Profile
Firmenname
Labcorp Holdings Inc
Sektor
Branche
Telefon
(336) 229-1127
Adresse
358 S MAIN ST, BURLINGTON, NC
Compare LH vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LH
Labcorp Holdings Inc
|
280.85 | 23.32B | 13.77B | 856.40M | 1.38B | 10.18 |
|
TMO
Thermo Fisher Scientific Inc
|
512.69 | 190.90B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
204.73 | 144.26B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
648.70 | 50.60B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
120.54 | 33.67B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
319.04 | 30.62B | 3.17B | 642.63M | 516.49M | 10.77 |
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-10 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-04-02 | Eingeleitet | Redburn Atlantic | Buy |
| 2025-03-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-01-07 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-12-10 | Fortgesetzt | Jefferies | Buy |
| 2024-10-30 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-10-01 | Eingeleitet | Piper Sandler | Neutral |
| 2024-03-25 | Hochstufung | Argus | Hold → Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-09 | Eingeleitet | Evercore ISI | In-line |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2023-09-06 | Eingeleitet | HSBC Securities | Hold |
| 2022-12-12 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-09-19 | Herabstufung | Argus | Buy → Hold |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-01-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-01-11 | Hochstufung | Argus | Hold → Buy |
| 2021-01-11 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2021-01-08 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-07-14 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-13 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | Fortgesetzt | Deutsche Bank | Buy |
| 2020-05-15 | Hochstufung | Mizuho | Neutral → Buy |
| 2020-04-29 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-04-27 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-04-27 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2019-07-16 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-06-21 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2019-04-02 | Hochstufung | Jefferies | Hold → Buy |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2019-01-03 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | Herabstufung | Craig Hallum | Buy → Hold |
| 2018-10-30 | Herabstufung | Argus | Buy → Hold |
| 2018-10-25 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2018-10-19 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-06-07 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-05-01 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2018-03-23 | Eingeleitet | Argus | Buy |
Alle ansehen
Labcorp Holdings Inc Aktie (LH) Neueste Nachrichten
Is Now an Ideal Moment to Include Labcorp Shares in Your Investment Portfolio? - Bitget
Is This the Right Time to Hold Labcorp Stock in Your Portfolio? - Nasdaq
Elo Mutual Pension Insurance Co Invests $3.58 Million in Labcorp Holdings Inc. $LH - MarketBeat
LH Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Labcorp Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Insider Sell: van der Vaart Sandra D Sells Shares of Labcorp Hol - GuruFocus
Labcorp EVP van der Vaart sells $155,999 in common stock By Investing.com - Investing.com UK
Adam Schechter sells 5,273 shares in Laboratory Corp (NYSE: LH) - Stock Titan
Insider Selling: Labcorp (NYSE:LH) EVP Sells 548 Shares of Stock - MarketBeat
Labcorp EVP van der Vaart sells $155,999 in common stock - Investing.com
Labcorp (NYSE: LH) EVP reports open-market insider stock sale - Stock Titan
Victory Capital Management Inc. Buys 440,224 Shares of Labcorp Holdings Inc. $LH - MarketBeat
Baird Adjusts Price Target on Labcorp Holdings to $325 From $326, Maintains Outperform Rating - marketscreener.com
Labcorp Holdings Inc. (LH) Stock Analysis: Strong Buy Ratings and Strategic Expansion Drive Investor Interest - DirectorsTalk Interviews
Handelsbanken Fonder AB Acquires 9,231 Shares of Labcorp Holdings Inc. $LH - MarketBeat
Is It Time To Reconsider Labcorp (LH) After Strong Healthcare Sector Coverage And DCF Upside? - Yahoo! Finance Canada
Did Labcorp’s 2026 Revenue Outlook and Buybacks Just Reframe Labcorp Holdings' (LH) Investment Narrative? - Yahoo Finance
Mitsubishi UFJ Asset Management Co. Ltd. Purchases 10,359 Shares of Labcorp Holdings Inc. $LH - MarketBeat
Labcorp Holdings Inc. $LH Shares Sold by American Century Companies Inc. - MarketBeat
Fidelity lists proposed sale of 548 LH shares (NYSE: LH) - Stock Titan
Citigroup Inc. Sells 29,736 Shares of Labcorp Holdings Inc. $LH - MarketBeat
Should Labcorp’s AI Pathology Push and Buybacks Recast the Long-Term Story for Labcorp (LH) Investors? - Sahm
LH SEC FilingsLabcorp Holdings Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Labcorp Holdings Inc.: - marketscreener.com
Labcorp Holdings Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Insider Sell: Brian Caveney Sells 1,500 Shares of Labcorp Holdin - GuruFocus
Brian Caveney Sells 1,500 Shares of Labcorp (NYSE:LH) Stock - MarketBeat
Labcorp Holdings Insider Sold Shares Worth $429,458, According to a Recent SEC Filing - marketscreener.com
Caveney Brian J, EVP at Labcorp, sells $429k in stock - Investing.com
Labcorp (LH) EVP Brian Caveney sells 1,500 shares in open trade - Stock Titan
Labcorp Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
Ex-Dividend Reminder: MGE Energy, Labcorp Holdings and Baxter International - Nasdaq
Labcorp Holdings Inc. $LH Shares Bought by Dakota Wealth Management - MarketBeat
Decoding Labcorp Holdings Inc (LH): A Strategic SWOT Insight - GuruFocus
Labcorp expands PathAI pact to roll out digital pathology platform in US - Yahoo Finance
LABCORP HOLDINGS INC. SEC 10-K Report - TradingView
LH (NYSE: LH) filer lists restricted-stock vesting and planned dispositions - Stock Titan
What Analysts Are Saying About Labcorp Hldgs Stock - Benzinga
Piper Sandler Adjusts Price Target on Labcorp Holdings to $300 From $270, Maintains Neutral Rating - marketscreener.com
The 5 Most Interesting Analyst Questions From Labcorp's Q4 Earnings Call - Finviz
Insider Sell: Peter Wilkinson Sells Shares of Labcorp Holdings I - GuruFocus
Labcorp Holdings Inc. (LH) Stock Analysis: A Promising 8.21% Potential Upside for Investors - DirectorsTalk Interviews
Labcorp SVP Wilkinson sells $185k in stock By Investing.com - Investing.com UK
Labcorp (LH) Expands PathAI Collaboration with New Pathology Pla - GuruFocus
Labcorp SVP Wilkinson sells $185k in stock - Investing.com
Labcorp (NYSE: LH) SVP logs 666-share preset stock sale - Stock Titan
Labcorp expands PathAI collaboration for digital pathology rollout - Investing.com
Labcorp (LH) Expands AI Collaboration with PathAI to Enhance Dia - GuruFocus
Labcorp Expands Collaboration with PathAI to Deploy FDA-Cleared Digital Pathology Platform Nationwide - Finviz
Labcorp Expands Collaboration With PathAI To Deploy AISight Dx Digital Pathology Platform - Nasdaq
Labcorp expands collaboration with PathAI to deploy FDA-cleared digital pathology platform - marketscreener.com
Finanzdaten der Labcorp Holdings Inc-Aktie (LH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.04%
2.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):